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Passive tension over the entire range of sarcomere lengths did not differ be-
tween sarcomere-mutation positive and mutation-negative male HCM patients.
Passive tension in myocytes from sarcomere mutation-positive women was
significantly higher compared to female mutation-negative HCM patients. Fe-
male MYH7 cardiomyocytes showed a higher sarcomere stiffness compared to
male MYH7.
Conclusion
Our measurements suggest that high sarcomere passive stiffness may
contribute to diastolic dysfunction in female HCM patients harboring a muta-
tion in genes encoding thick filament proteins.
1751-Pos Board B481
Sex-Related Differences in Myosin Heavy Chain Isoforms of Human
Failing and Non-Failing Atria
Peter J. Reiser1, Christine S. Moravec2.
1Oral Biology, Ohio State University, Columbus, OH, USA, 2Kaufman
Center for Heart Failure, Cleveland Clinic, Cleveland, OH, USA.
Mammalian hearts express two myosin heavy chain (MHC) isoforms, which
drive contractions with different kinetics and power-generating ability. The
expression of the isoform that is associated with more rapid contraction kinetics
and greater power output, MHC-a, is down-regulated, with a concurrent in-
crease in the relative amount of the slower isoform, MHC-b, during the pro-
gression to experimentally-induced or disease-related heart failure. This
change in protein expression has been well studied in right and left ventricles
in heart failure models and in humans with failure. Relatively little quantitative
data exists regarding MHC isoform expression shifts in human failing atria. We
previously reported significant increases in the relative amount of MHC-b in
the human failing left atrium. The results of that study suggested that there
might be a sex-related difference in the level of MHC-b in the left atrium,
but the number of female subjects was insufficient for statistical analysis.
The objective of this study was to test whether there is, in fact, a sex-related
difference in the level of MHC-b in the right and left atria of humans with car-
diomyopathy. The results indicate that significant differences exist in atrial
MHC isoform expression between men and women who are in failure. The re-
sults unexpectedly also revealed a two-fold greater amount of MHC-b in the
non-failing left atrium of women, compared to men. The observed sex-
related differences in MHC isoform expression could impact ventricular dia-
stolic filling during normal daily activities, as well as during physiologically
stressful events.
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Rationale: Myocardial infarction (MI) is associated with depressed cardiac con-
tractile function and progression to heart failure. Cardiac myosin binding
protein-C (cMyBP-C), a cardiac-specific myofilament protein, is proteolyzed
post-MI in humans and results in an N-terminal fragment, C0C1f. The presence
of C0C1f in cultured adult cardiomyocytes results in decreased Ca2þ transients
and cell shortening, in addition to the induction of heart failure in a mouse
model. However, the underlying mechanisms remain unclear.
Objective: To determine how C0C1f causes altered contractility in human car-
diac myofilaments in vitro.
Methods and Results: We generated recombinant human C0C1f (hC0C1f) and
incorporated it into skinned human left ventricular myocytes. Mechanical prop-
erties were then studied at sarcomere lengths of 2.0 and 2.3 mm. Our data
demonstrate that the presence of hC0C1f in the sarcomere decreased maximal
force myofilament Ca2þ sensitivity, increased cooperative activation at short
lengths and enhanced length-dependent activation. Furthermore, hC0C1f led
to increased cross-bridge cycling kinetics and tension cost at both short and
long sarcomere lengths. We further established that the detrimental effects of
hC0C1f occur through direct interaction with the thin filament proteins actin
and a-tropomyosin (a-TM).Conclusions: Our data demonstrate that the presence of hC0C1f in the sarco-
mere is sufficient to induce depressed myofilament function and Ca2þ sensi-
tivity in otherwise healthy human donor myofilament preparations.
Decreased cardiac function post-MI may result, in part, from the ability of
hC0C1f to bind actin and a-TM, suggesting that cleaved C0C1f could act as
a poison peptide and disrupt the interaction of native cMyBP-C with the thin
filament.
Keywords: Cross-bridge cycling kinetics; length-dependent activation;
cMyBP-C; C0C1f protein.
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Background: Rest or exercise obstruction is present in two thirds of patients
with hypertrophic cardiomyopathy (HCM) and is a major determinant of symp-
toms and disability. Hypercontractile upper septum is the main pathophysiolog-
ical determinant of obstruction, thus negative inotropic interventions such as
dysopiramide or beta-blockers are the only available options to pharmacolog-
ically treat obstruction, commonly with partial efficacy. We have previously
demonstrated that ranolazine ameliorates diastolic function in trabeculae
from septal samples of obstructive HCM patients undergoing myectomy (Cop-
pini et al, Circulation 2013).
Methods: Patch clamp studies and intracellular Ca2þ recordings were per-
formed in isolated myocytes from myectomy samples of obstructive HCM pa-
tients; intact trabeculae were used for mechanical measurements. Myocardial
specimens from non-failing non-hypertrophic patients or patients with second-
ary hypertrophy were used as controls.
Results: Dysopiramide (Dys) reduced twitch tension in a dose dependent
manner and 5mM Dys accelerated contraction kinetics in HCM trabeculae.
Isoproterenol 107 mol/L (Iso) determined a significant potentiation of twitch
amplitude and an accelleration of contraction kinetics (both time to peak and
relaxation). Changes induced by Iso in control trabeculae were similar. Inter-
estingly, Iso caused APD prolongation in HCM cardiomyocytes instead of
the shortening observed in control cells. This was likely related to the unbal-
ance between depolarizing and repolarizing currents, including increased
Late-Naþ current (INaL). The INaL blocker Ranolazine 10 mM (Ran) applied
on top of Iso (IsoþRan) markedly reduced isometric twitch tension of
HCM trabeculae, while Ran alone showed no negative inotropic effect.
Contraction kinetics in IsoþRan were still significantly faster compared to
baseline.
Conclusions: Beta adrenergic stimulation may enhance septal contractility
and determine obstruction in HCM. Ranolazine, by reducing septal tension at
peak exercise but not at rest, may represent a safe therapeutic option for
obstruction.
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We examined the role of missense and nonsense myosin-binding protein
mutations in human tissue of patients with hypertrophic cardiomyopathy
in an essentially unloaded isotonic system by partial Ca2þ-activation, i.e.
Ca-spontaneous oscillary contractions (SPOC). Despite considerable litera-
ture suggesting that hypercontractility is a feature of HCM-causing muta-
tions, we observe: (1) prolonged durations of both the lengthening
(p<0.0001) and shortening (p<0.001) phases of the SPOC cycle in
MYBPC3 mutants; (2) depressed contractility where the rates of both
lengthening (P<0.01) and shortening (p<0.05) were reduced; however (3)
the amplitude of the SPOC cycles did not vary between mutated MYBPC3
and healthy donor samples under essentially unloaded isotonic conditions.
We found no difference between MYBPC3 samples containing missense
or nonsense mutations. Unexpectedly, principal component analysis demon-
strated that the contractile properties of human derived cardiomyocytes un-
der low-load conditions were distinctively different for mutations in
MYBPC3 and troponin genes. We conclude that, at least under the isotonic
